Evidence map›Paper›PMID 33610552›Full record

ReviewThe Journal of biological chemistry

Amino acid-derived defense metabolites from plants: A potential source to facilitate novel antimicrobial development.

Anutthaman Parthasarathy, Eli J Borrego, Michael A Savka, Renwick C J Dobson, André O Hudson

Open access · goldAbstract readReview
In one paragraph

Review in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Metabolome Profiling ofInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Anutthaman ParthasarathyRochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, Rochester, New York, USA.
Eli J BorregoRochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, Rochester, New York, USA.
Michael A SavkaRochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, Rochester, New York, USA.
Renwick C J DobsonBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand; Bio21 Molecular Science and Biotechnology Institute, Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.
André O HudsonRochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, Rochester, New York, USA. Electronic address: aohsbi@rit.edu.
Rochester Institute of Technology · USThe University of Melbourne · AU

Funding

Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistanceR15GM144862 · NIGMS · ROCHESTER INSTITUTE OF TECHNOLOGY · PI HUDSON, ANDRE O · 2021 to 2022
$544k
Genetic and structural analysis of L,L-diaminopimelate aminotransferase (DapL): An attractive target for the development of narrow-spectrum antibioticsR15GM120653 · NIGMS · ROCHESTER INSTITUTE OF TECHNOLOGY · PI HUDSON, ANDRE O · 2016 to 2017
$468k
NIGMS NIH HHS R15 GM120653NIGMS NIH HHS R15 GM144862
6 · The paper itself

Abstract

For millennia, humanity has relied on plants for its medicines, and modern pharmacology continues to reexamine and mine plant metabolites for novel compounds and to guide improvements in biological activity, bioavailability, and chemical stability. The critical problem of antibiotic resistance and increasing exposure to viral and parasitic diseases has spurred renewed interest into drug treatments for infectious diseases. In this context, an urgent revival of natural product discovery is globally underway with special attention directed toward the numerous and chemically diverse plant defensive compounds such as phytoalexins and phytoanticipins that combat herbivores, microbial pathogens, or competing plants. Moreover, advancements in "omics," chemistry, and heterologous expression systems have facilitated the purification and characterization of plant metabolites and the identification of possible therapeutic targets. In this review, we describe several important amino acid-derived classes of plant defensive compounds, including antimicrobial peptides (e.g., defensins, thionins, and knottins), alkaloids, nonproteogenic amino acids, and phenylpropanoids as potential drug leads, examining their mechanisms of action, therapeutic targets, and structure-function relationships. Given their potent antibacterial, antifungal, antiparasitic, and antiviral properties, which can be superior to existing drugs, phytoalexins and phytoanticipins are an excellent resource to facilitate the rational design and development of antimicrobial drugs.

Indexed as

Amino AcidsAnti-Infective AgentsDrug DevelopmentPhytochemicalsPlantsAmino AcidsAnti-Infective AgentsPhytochemicalsamino acidsantibiotic resistanceplant defenseplantssecondary metabolites

Identifiers

PMID33610552
PMCPMC8024917
OpenAlexW3130425237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.